Kronos Bio, Inc. (KRON)
USD 0.95
(-0.66%)
USD 0.95
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.58 Million | -90.92 Million | -117.92 Million | -37.91 Million | -15.08 Million | -6.44 Million |
| Net Income | -112.67 Million | -133.2 Million | -151.07 Million | -88.44 Million | -16.11 Million | -6.72 Million |
| Depreciation & Amortization | 4.91 Million | 2.26 Million | 1.97 Million | 839 Thousand | 356 Thousand | 91 Thousand |
| Deferred income taxes | 4.14 Million | - | 3.99 Million | 326 Thousand | -4000.00 | - |
| Stock-based compensation | 24.98 Million | 31.14 Million | 26.21 Million | 3.75 Million | 113 Thousand | 30 Thousand |
| Change in working capital | 5.87 Million | 6.17 Million | -1.62 Million | 6.46 Million | 276 Thousand | 90 Thousand |
| Other non-cash items | -5.83 Million | 2.68 Million | 2.58 Million | 39.15 Million | 294 Thousand | 69 Thousand |
| Investing Cash Flow | 66.36 Million | -32.22 Million | 63.72 Million | -160.23 Million | -67.58 Million | -1.07 Million |
| Investments in PPE | -679 Thousand | -577 Thousand | -4.26 Million | -9.56 Million | -2.94 Million | -1.07 Million |
| Acquisitions | - | 31.64 Million | -67.98 Million | 150.66 Million | - | - |
| Investment purchases | -212.95 Million | -367.12 Million | -177.73 Million | -229.32 Million | -64.63 Million | - |
| Sales/Maturities of investments | 280 Million | 335.47 Million | 245.71 Million | 78.66 Million | - | - |
| Other Investing Activities | -1.00 | -31.64 Million | 67.98 Million | -150.66 Million | -64.63 Million | - |
| Financing Cash Flow | 567 Thousand | 851 Thousand | 4.46 Million | 415.61 Million | 105 Million | 16.21 Million |
| Debt repayment | - | - | -5000.00 | -32 Thousand | -30 Thousand | -72 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 538 Thousand | 380 Thousand | 1.33 Million | - | - | - |
| Common Stock Issuance | 567 Thousand | 851 Thousand | 4.46 Million | 263.72 Million | 115 Thousand | 5000.00 |
| Other Financing Activities | 567 Thousand | 851 Thousand | 4.46 Million | 151.92 Million | 104.92 Million | 16.28 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -4.14 Million | 4.02 Million | -3.19 Million | 2.8 Million | 716 Thousand | -28 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.02 Million | 2.15 Million | 1.57 Million | 3.65 Million | -440 Thousand | 118 Thousand |
| Cash at beginning of period | 75.97 Million | 200.29 Million | 250.03 Million | 32.57 Million | 10.22 Million | 1.52 Million |
| Cash at end of period | 64.32 Million | 77.99 Million | 200.29 Million | 250.03 Million | 32.57 Million | 10.22 Million |
| Capital Expenditure | -679 Thousand | -577 Thousand | -4.26 Million | -9.56 Million | -2.94 Million | -1.07 Million |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -11.64 Million | -122.29 Million | -49.74 Million | 217.46 Million | 22.34 Million | 8.7 Million |
| Free Cash Flow | -79.26 Million | -91.5 Million | -122.18 Million | -47.48 Million | -18.03 Million | -7.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.2 Million | -29.95 Million | -25.32 Million | -112.67 Million | -31.37 Million | -29.74 Million |
| Depreciation & Amortization | 420 Thousand | 1.27 Million | 478 Thousand | 4.91 Million | 510 Thousand | 579 Thousand |
| Deferred income taxes | - | - | -9.33 Million | 4.14 Million | -1.36 Million | 1.43 Million |
| Stock-based compensation | 2.2 Million | 3.32 Million | 5.17 Million | 24.98 Million | 6.29 Million | 6.9 Million |
| Change in working capital | -3.29 Million | -8.59 Million | -5.29 Million | 5.87 Million | 2.59 Million | -4.99 Million |
| Other non-cash items | 4.82 Million | 14.57 Million | 9.27 Million | -5.83 Million | 752 Thousand | 796 Thousand |
| Investing Cash Flow | 40.17 Million | 5.77 Million | 31.56 Million | 66.36 Million | 35.78 Million | 5.37 Million |
| Investments in PPE | - | -7000.00 | -31 Thousand | -679 Thousand | -214 Thousand | -308 Thousand |
| Acquisitions | - | - | -31.59 Million | - | -36 Million | -5.68 Million |
| Investment purchases | -6.4 Million | -48.75 Million | -42.14 Million | -212.95 Million | -30.49 Million | -37.72 Million |
| Sales/Maturities of investments | 46.57 Million | 54.53 Million | 73.73 Million | 280 Million | 66.49 Million | 43.4 Million |
| Other Investing Activities | 40.17 Million | 5.77 Million | 31.59 Million | -1.00 | 36 Million | 5.68 Million |
| Financing Cash Flow | 164 Thousand | - | 191 Thousand | 567 Thousand | - | 376 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 538 Thousand | 538 Thousand | - | - |
| Common Stock Issuance | - | - | 191 Thousand | 567 Thousand | - | 376 Thousand |
| Other Financing Activities | 164 Thousand | - | 191 Thousand | 567 Thousand | - | 376 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.23 Million | 1.34 Million | -3.2 Million | -4.14 Million | 1.6 Million | -3.55 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.05 Million | -9.94 Million | -2.09 Million | 10.02 Million | 993 Thousand | -1.44 Million |
| Cash at beginning of period | 46.19 Million | 64.32 Million | 57.59 Million | 75.97 Million | 46.42 Million | 65.69 Million |
| Cash at end of period | 70.2 Million | 46.19 Million | 64.32 Million | 64.32 Million | 59.62 Million | 46.42 Million |
| Capital Expenditure | - | -7000.00 | -31 Thousand | -679 Thousand | -214 Thousand | -308 Thousand |
| Effect of forex changes on cash | - | - | -1.00 | 1.00 | - | - |
| Net cash flow / Change in cash | 24.01 Million | -18.12 Million | 6.72 Million | -11.64 Million | 13.2 Million | -19.27 Million |
| Free Cash Flow | -16.32 Million | -23.9 Million | -25.05 Million | -79.26 Million | -22.8 Million | -25.33 Million |
ALSTW
VIRT
GMT
ACSYF
688778
1110